Minireviews
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Methodol. Dec 20, 2024; 14(4): 92246
Published online Dec 20, 2024. doi: 10.5662/wjm.v14.i4.92246
Pharmacological adjuvants for diabetic vitrectomy surgery
Ramesh Venkatesh, Chaitra Jayadev, Vishma Prabhu, Priyanka Gandhi, Rupal Kathare, Naresh K Yadav, Ayushi Choudhary, Jay Chhablani
Ramesh Venkatesh, Department of Ophthalmology, Narayana Nethralaya, Bangalore 560010, India
Chaitra Jayadev, Vishma Prabhu, Priyanka Gandhi, Rupal Kathare, Ayushi Choudhary, Department of Retina, Narayana Nethralaya Eye Institute, Bangalore 560010, India
Naresh K Yadav, Department of Vitreo Retina, Narayana Nethralaya, Retina Serv, Super Specialty Eye Hospital and Post Graduate Institute of Ophthalmology, Bangalore 560010, India
Jay Chhablani, Department of Retina, University of Pittsburg School of Medicine, Pittsburg, PA 15213, United States
Author contributions: Venkatesh R writing, critical review and revising the manuscript; Jayadev C, Prabhu V, Yadav NK reviewing the manuscript; Gandhi P, Kathare R, Choudhary A assisting in writing the manuscript; Chhablani J critical review of the manuscript.
Conflict-of-interest statement: None of the authors have anything to declare.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ramesh Venkatesh, MBBS, MD, MS, Doctor, Surgeon, Department of Ophthalmology, Narayana Nethralaya, 121/C. 1st R block, West of Chord Road, Rajaji Nagar, Bangalore 560010, India. vramesh80@yahoo.com
Received: January 20, 2024
Revised: June 26, 2024
Accepted: July 5, 2024
Published online: December 20, 2024
Processing time: 188 Days and 6.9 Hours
Core Tip

Core Tip: For advanced diabetic retinopathy, diabetic vitrectomy is a complex procedure with unpredictable outcomes. In the last decade, intravitreal pharmacotherapy has advanced, providing new ways to improve surgical outcomes for our patients. In medicine, an "adjunct" refers to a drug or substance that supplements the main treatment. This review will look at the pharmacological adjuncts used in diabetic vitrectomy surgery and how they affect specific steps. The categorization system enables surgeons to anticipate surgical issues and select the appropriate pharmacological agent to address them, thereby increasing surgical success rates.